GSK adapts to changing pharmaceutical business model
One of the first big drug makers to hit the so-called patent cliff, GlaxoSmithKline (GSK), has responded to a changing industry business model by rethinking its strategic positioning and adopting a more balanced approach to the evolving health care marketplace.